Skip to main content

Lung Cancer Pharmacotherapy

Course Experts: Maria Vecchiarelli Kimball, PharmD, BCOP

Course Description: This course provides an overview of chemotherapy, immunotherapy, and targeted therapy families of drugs that are commonly used in the treatment of small cell and non-small cell lung cancer. It identifies common treatment regimens, adverse effects, and unique toxicities pertinent to each agent or combination regimen.

Credits: CEUs will be granted for pharmacists in disease state management/drug therapy.

Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Chemotherapy, Biotherapy, Targeted Therapy, Adverse Effects, Taxanes, Alkylating Agents, Antimetabolites, Topoisomerase Inhibitors, Vinca Alkaloids, Immune Checkpoint Inhibitors (ICI), Kinase Inhibitors, Neoadjuvant Treatment, Adjuvant Treatment, Peripheral Neuropathy, Hypersensitivity Reactions, Immune-Related Adverse Events (irAEs), Consolidation Immunotherapy